Success mixing responsibility research, social, and profit in Yissum and Hebrew university of JerusalemTag: university, nanotechnology, technology Category:post: 04 Apr 2008 read: 54 There is a stigma if a education institution only responsible in research and invention without considering commercial sides. a long debate during through years about that limit firmness. these rumors is almost always in entire worldwide. Actually, there is nothing wrong a university increases involving, beside research that affect social, all at once implement in commercial side. this contribution enhanced will make image that university is a place that have real role. This debate apparently complete at Hebrew University of Jerusalem. this university has a service under Yissum (a Technology Transfer Services at the Hebrew University of Jerusalem). Hebrew University of Jerusalem has brilliant accomplishment note. During more than 20 year produce more than 1500 patent, 750 active and 250 be licenced. All those patent acres protected with university's intellectual property protection and commercialization. in the year 2007 alone, Yissum produce 91 patent submission, accept 121 disclosures and awarded 59 new patents worldwide. It is interesting, from commercial side, Yissum put Hebrew University of Jerusalem in 15 top universities worldwide, which is worth equal to 1 billion of Hebrew University Technology sales worldwide each year. look their is report at 2005, Yissum's earned around 35 million. See their project. Their achievement in commercialization part was generated by handle up to 400 projects in 2007 alone. Still in that year, they succeed to signed 418 agreements, is 33 of them were option agreements. Like a profit company, Yissum also do Initial Public Offering. They enjoyed first IPA offering of one of its companies on the tel aviv stock exchange in December 2005, nasvax ltd. this company, based on technology from prof. Chezy Barenholz, was successfully. now, they have 10 million in the bank. it happen because has in clinical trials with its influenza vaccine. Another proud achievement from last year report were from one of Yissum’s divisions. This division, BioCancell Inc, increase their fund for over US$3 million, from private investors and from Hebrew University's pension fund. BioCancell Inc. had successfully began some clinical trials on their previous research on bladder cancer patient, which is based on H19 therapy. their long road since year 1964. Yissum was founded to protect the Hebrew university's intellectual property and commercialize it. this a where at that moment university product commercialization still to be matter sensitive. this point of view get result. Until now Yissum (as a Technology Transfer University) success be partner fame companies such as Novarties, Microsoft, Johnson & Johnson, Merck, Informer, Teva, and many more. The Yissum's dedication to education and research world is no doubt. One of proof, Yissum take part in sponsoring NIH of a grant application by prof. raymond kaempfer. via atox bio inc. Prof. Raymond Kaempfer biodefence applications of super-antigens is successfully granted us$ 5.6 million. this full support proof Yissum to atox bio. One of proud that they known as Center for Nanoscience and Nanotechnolog. Nanotechnology is an enabling technology for diverse fields and applications, and is expected to be the revolutionary force for industrial and economical development in the 21st century. This is exciting field of research at the forefront of modern science and technology. They promotes close ties with industry to achieve implementation of the scientific discoveries in real-life applications. This success mixing research, social responsibility, and commercial side begins to be followed by other universities at US, Europe, and Japan. Yissum success inspired many universities to follow the trace. success builds new technology for life better. |
| | Give Your Opinion | Recommend |
|
